Enterprise Value
$3.28 B
-$198.89 M-5.73%
Thu, 13 Mar 2025 23:55:22 GMT
Summary
- As of March 14, 2025, PTGX enterprise value is $3.28 billion, with a fall of -$198.89 million (-5.73%) during the most recent trading day.
- Over the past year, PTGX enterprise value has increased by +$1.89 billion (+136.58%).
- PTGX enterprise value is now -8.16% below its all-time high of $3.57 billion.
Performance
PTGX Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
PTGX Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | -5.7% | -5.6% | -5.6% |
| 1 m1 month | +46.7% | +44.9% | +44.1% |
| 3 m3 months | +38.0% | +34.8% | +30.9% |
| 6 m6 months | +23.5% | +21.3% | +16.4% |
| ytdytd | +44.3% | +42.7% | +41.9% |
| 1 y1 year | +136.6% | +114.1% | +103.3% |
| 5 y5 years | +1532.1% | +1451.5% | +593.2% |
PTGX Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -8.2% | $2.07 B | +58.4% | |
| 3 m | 3-month | $3.57 B | -8.2% | $2.07 B | +58.4% |
| 6 m | 6-month | $3.57 B | -8.2% | $2.07 B | +58.4% |
| 1 y | 1-year | $3.57 B | -8.2% | $1.27 B | +157.1% |
| 3 y | 3-year | $3.57 B | -8.2% | $214 M | +1433.8% |
| 5 y | 5-year | $3.57 B | -8.2% | $126 M | +2491.8% |
| alltime | all time | $3.57 B | -8.2% | $57 M | +5602.2% |
Protagonist Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2024 | $2.27 B(+99.5%) |
| 2023 | $1.14 B(+188.4%) |
| 2022 | $394.49 M(-74.0%) |
| 2021 | $1.52 B(+97.0%) |
| Date | Value |
|---|---|
| 2020 | $770.51 M(+338.1%) |
| 2019 | $175.89 M(+138.3%) |
| 2018 | $73.82 M(-77.8%) |
| 2017 | $332.61 M(-4.0%) |
| 2016 | $346.64 M |
FAQ
- What is Protagonist Therapeutics enterprise value?
- What is the all time high enterprise value for Protagonist Therapeutics?
- What is PTGX enterprise value year-to-date change?
- What is Protagonist Therapeutics enterprise value year-on-year change?
What is Protagonist Therapeutics enterprise value?
The current enterprise value of PTGX is $3.28 B
What is the all time high enterprise value for Protagonist Therapeutics?
Protagonist Therapeutics all-time high enterprise value is $3.57 B
What is PTGX enterprise value year-to-date change?
Protagonist Therapeutics enterprise value has changed by +$1.01 B (+44.30%) since the beginning of the year
What is Protagonist Therapeutics enterprise value year-on-year change?
Over the past year, PTGX enterprise value has changed by +$1.89 B (+136.58%)